Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing

Keyphrases

• Akt-mTOR Signaling 12%
• Anticancer Treatment 12%
• Cervical Cancer 12%
• Diagnosis Prediction 12%
• ErbB4 37%
• Gene Ontology 12%
• Gene-based 12%
• Immunohistochemical Staining 12%
• Long Non-coding RNA (LncRNA) 12%
• Missense 12%
• Mutated Genes 25%
• Mutation Profiling 100%
• Neuroendocrine Tumor 12%
• Neuroendocrine Tumor Cell Lines 12%
• Non-tumor Tissue 12%
• Nonsense 12%
• Pancreatic Neuroendocrine Tumors (pNETs) 12%
• PI3K-AKT-mTOR Pathway 12%
• Prognosis Prediction 12%
• Publicly Available Data 12%
• Small Cell Lung Cancer 12%
• Small Cell Neuroendocrine 100%
• Small Intestinal Neuroendocrine Tumors 12%
• Somatic mutation 25%
• Splice Site 12%
• Start Codon mutation 12%
• Treatment Strategy 25%
• Tumor 12%
• Tumor Marker 12%
• Tumor mutation Burden 100%
• Tumor-normal 12%
• Tumorigenesis 12%
• Whole Exome Sequencing 100%

Biochemistry, Genetics and Molecular Biology

• Alpha Thalassemia/Mental Retardation X-Linked 25%
• Carcinogenesis 12%
• ERBB4 37%
• Exome Sequencing 100%
• Gene Ontology 12%
• Long Non-Coding RNA 12%
• Mammalian Target of Rapamycin 12%
• Missense 12%
• mTOR Signaling 12%
• Mutated Genes 25%
• Neuroendocrine Cell 100%
• Small Intestine 12%
• Somatic Mutation 25%
• Start Codon 12%
• Tumor Marker 12%

Medicine and Dentistry

• Cancer Therapy 10%
• Carcinogenesis 10%
• Cervical Cancer 10%
• Diagnosis 10%
• Exome Sequencing 100%
• Long Untranslated RNA 10%
• Mammalian Target of Rapamycin 10%
• mTOR Signaling 10%
• Neoplasm 20%
• Neuroendocrine Tumor 100%
• Neuroendocrine Tumor Cell Line 10%
• Pancreas Islet Cell Tumor 10%
• Small Cell Lung Cancer 10%
• Small Intestine 10%
• Somatic Mutation 20%
• Start Codon 10%
• Tumor Marker 10%